Skip to main content
Top
Published in: Respiratory Research 1/2020

Open Access 01-12-2020 | Smoking and Nicotine Detoxification | Research

Evaluation of secondhand smoke effects on CFTR function in vivo

Authors: Lawrence W. Rasmussen, Denise Stanford, Krina Patel, S. Vamsee Raju

Published in: Respiratory Research | Issue 1/2020

Login to get access

Excerpt

Cystic fibrosis transmembrane conductance regulator (CFTR) is an anion channel expressed on the mucosal surface of epithelial cells lining several tissues including airways. Inherited defects in the CFTR gene cause cystic fibrosis (CF), an autosomal recessive disease causing a progressive decline in lung function ultimately resulting in reduced life span. CF patients exhibit impaired mucociliary clearance (MCC), a principle defense of airways against inhaled irritants and pathogens. The MCC apparatus consists of airway surface liquid (ASL), which has a mucus layer that traps pathogens to be removed by the coordinated beating of surface cilia [1]. Physiologic levels of ASL and PCL determine the effectiveness of MCC, a process tightly regulated through CFTR activity [2, 3]. As a result of reduced CFTR-mediated ion transport, CF airways fail to maintain optimal surface hydration and clear inhaled pathogens. Decreased MCC efficiency causes accumulation of thick mucus, opportunistic infections, and chronic inflammation. Beyond inherited defects, several different environmental insults can also negatively affect CFTR function even in those with normal genetics. For example, exposure to cigarette smoke is known to cause decreased CFTR activity in mice [4], rats [5], ferrets [6], dogs [7], and humans [8, 9]. Reports also suggest excessive alcohol intake [10] and exposure to cadmium [11] and arsenic [12, 13] result in diminished CFTR activity supporting the concept of ‘acquired CFTR dysfunction’. …
Appendix
Available only for authorised users
Literature
2.
go back to reference Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006;354:241–50.PubMedCrossRef Donaldson SH, Bennett WD, Zeman KL, Knowles MR, Tarran R, Boucher RC. Mucus clearance and lung function in cystic fibrosis with hypertonic saline. N Engl J Med. 2006;354:241–50.PubMedCrossRef
3.
go back to reference Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL, Worthington EN, Gentzsch M, Kreda SM, Cholon D, et al. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J. 2011;26(2):53. Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL, Worthington EN, Gentzsch M, Kreda SM, Cholon D, et al. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J. 2011;26(2):53.
4.
go back to reference Raju SV, Jackson PL, Courville CA, McNicholas CM, Sloane PA, Sabbatini G, Tidwell S, Tang LP, Liu B, Fortenberry JA, et al. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med. 2013;188:1321–30.PubMedPubMedCentralCrossRef Raju SV, Jackson PL, Courville CA, McNicholas CM, Sloane PA, Sabbatini G, Tidwell S, Tang LP, Liu B, Fortenberry JA, et al. Cigarette smoke induces systemic defects in cystic fibrosis transmembrane conductance regulator function. Am J Respir Crit Care Med. 2013;188:1321–30.PubMedPubMedCentralCrossRef
5.
go back to reference McCormick LL, Phillips SE, Kaza N, Tang LP, Rasmussen L, Byzek SA, Raju SV, Rowe SM. Maternal smoking induces acquired CFTR dysfunction in neonatal rats. Am J Respir Crit Care Med. 2018;198:672–4.PubMedPubMedCentralCrossRef McCormick LL, Phillips SE, Kaza N, Tang LP, Rasmussen L, Byzek SA, Raju SV, Rowe SM. Maternal smoking induces acquired CFTR dysfunction in neonatal rats. Am J Respir Crit Care Med. 2018;198:672–4.PubMedPubMedCentralCrossRef
6.
go back to reference Raju S, Trombley J, Kim H, Birket S, Lin V, Samuel S, Tang L, Warren M, Winter L, Dohm E. Acquired CFTR dysfunction in a novel ferret model Of copd. In: Pediatric pulmonology. Hoboken: Wiley; 2014. p. 246. Raju S, Trombley J, Kim H, Birket S, Lin V, Samuel S, Tang L, Warren M, Winter L, Dohm E. Acquired CFTR dysfunction in a novel ferret model Of copd. In: Pediatric pulmonology. Hoboken: Wiley; 2014. p. 246.
8.
go back to reference Knowles M, Gatzy J, Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med. 1981;305:1489–95.PubMedCrossRef Knowles M, Gatzy J, Boucher R. Increased bioelectric potential difference across respiratory epithelia in cystic fibrosis. N Engl J Med. 1981;305:1489–95.PubMedCrossRef
9.
go back to reference Dransfield MT, Wilhelm AM, Flanagan B, Courville C, Tidwell SL, Raju SV, Gaggar A, Steele C, Tang LP, Liu B, Rowe SM. Acquired cystic fibrosis Transmembrane conductance regulator dysfunction in the lower airways in COPD. Chest. 2013;144:498–506.PubMedPubMedCentralCrossRef Dransfield MT, Wilhelm AM, Flanagan B, Courville C, Tidwell SL, Raju SV, Gaggar A, Steele C, Tang LP, Liu B, Rowe SM. Acquired cystic fibrosis Transmembrane conductance regulator dysfunction in the lower airways in COPD. Chest. 2013;144:498–506.PubMedPubMedCentralCrossRef
11.
go back to reference Rennolds J, Butler S, Maloney K, Boyaka PN, Davis IC, Knoell DL, Parinandi NL, Cormet-Boyaka E. Cadmium regulates the expression of the CFTR chloride channel in human airway epithelial cells. Toxicol Sci. 2010;116:349–58.PubMedPubMedCentralCrossRef Rennolds J, Butler S, Maloney K, Boyaka PN, Davis IC, Knoell DL, Parinandi NL, Cormet-Boyaka E. Cadmium regulates the expression of the CFTR chloride channel in human airway epithelial cells. Toxicol Sci. 2010;116:349–58.PubMedPubMedCentralCrossRef
12.
go back to reference Bomberger JM, Coutermarsh BA, Barnaby RL, Stanton BA. Arsenic promotes ubiquitinylation and lysosomal degradation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels in human airway epithelial cells. J Biol Chem. 2012;287:17130–9.PubMedPubMedCentralCrossRef Bomberger JM, Coutermarsh BA, Barnaby RL, Stanton BA. Arsenic promotes ubiquitinylation and lysosomal degradation of cystic fibrosis transmembrane conductance regulator (CFTR) chloride channels in human airway epithelial cells. J Biol Chem. 2012;287:17130–9.PubMedPubMedCentralCrossRef
13.
go back to reference Mazumdar M, Christiani DC, Biswas SK, Ibne-Hasan OS, Kapur K, Hug C. Elevated sweat chloride levels due to arsenic toxicity. N Engl J Med. 2015;372:582–4.PubMedPubMedCentralCrossRef Mazumdar M, Christiani DC, Biswas SK, Ibne-Hasan OS, Kapur K, Hug C. Elevated sweat chloride levels due to arsenic toxicity. N Engl J Med. 2015;372:582–4.PubMedPubMedCentralCrossRef
14.
go back to reference Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988–2002. Environ Health Perspect. 2006;114:853–8.PubMedPubMedCentralCrossRef Pirkle JL, Bernert JT, Caudill SP, Sosnoff CS, Pechacek TF. Trends in the exposure of nonsmokers in the U.S. population to secondhand smoke: 1988–2002. Environ Health Perspect. 2006;114:853–8.PubMedPubMedCentralCrossRef
16.
go back to reference Gorzkowski JA, Klein JD. The role of secondhand smoke research in protecting nonsmokers. Pediatrics. 2018;141:S6–9.PubMedCrossRef Gorzkowski JA, Klein JD. The role of secondhand smoke research in protecting nonsmokers. Pediatrics. 2018;141:S6–9.PubMedCrossRef
17.
go back to reference Ebbert JO, Croghan IT, Schroeder DR, Murawski J, Hurt RD. Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional survey. Environ Health. 2007;6:28.PubMedPubMedCentralCrossRef Ebbert JO, Croghan IT, Schroeder DR, Murawski J, Hurt RD. Association between respiratory tract diseases and secondhand smoke exposure among never smoking flight attendants: a cross-sectional survey. Environ Health. 2007;6:28.PubMedPubMedCentralCrossRef
18.
go back to reference Harris JK, Luke DA, Zuckerman RB, Shelton SC. Forty years of secondhand smoke research: the gap between discovery and delivery. Am J Prev Med. 2009;36:538–48.PubMedCrossRef Harris JK, Luke DA, Zuckerman RB, Shelton SC. Forty years of secondhand smoke research: the gap between discovery and delivery. Am J Prev Med. 2009;36:538–48.PubMedCrossRef
19.
go back to reference Dayal HH, Khuder S, Sharrar R, Trieff N. Passive smoking in obstructive respiratory disease in an industrialized urban population. Environ Res. 1994;65:161–71.PubMedCrossRef Dayal HH, Khuder S, Sharrar R, Trieff N. Passive smoking in obstructive respiratory disease in an industrialized urban population. Environ Res. 1994;65:161–71.PubMedCrossRef
20.
go back to reference Lee PN, Chamberlain J, Alderson MR. Relationship of passive smoking to risk of lung cancer and other smoking-associated diseases. Br J Cancer. 1986;54:97–105.PubMedPubMedCentralCrossRef Lee PN, Chamberlain J, Alderson MR. Relationship of passive smoking to risk of lung cancer and other smoking-associated diseases. Br J Cancer. 1986;54:97–105.PubMedPubMedCentralCrossRef
21.
go back to reference Savitski AN, Mesaros C, Blair IA, Cohen NA, Kreindler JL. Secondhand smoke inhibits both cl- and K+ conductances in normal human bronchial epithelial cells. Respir Res. 2009;10:120.PubMedPubMedCentralCrossRef Savitski AN, Mesaros C, Blair IA, Cohen NA, Kreindler JL. Secondhand smoke inhibits both cl- and K+ conductances in normal human bronchial epithelial cells. Respir Res. 2009;10:120.PubMedPubMedCentralCrossRef
22.
go back to reference Habesoglu M, Demir K, Yumusakhuylu AC, Yilmaz AS, Oysu C. Does passive smoking have an effect on nasal mucociliary clearance? Otolaryngol Head Neck Surg. 2012;147:152–6.PubMedCrossRef Habesoglu M, Demir K, Yumusakhuylu AC, Yilmaz AS, Oysu C. Does passive smoking have an effect on nasal mucociliary clearance? Otolaryngol Head Neck Surg. 2012;147:152–6.PubMedCrossRef
23.
go back to reference Wu CF, Feng NH, Chong IW, Wu KY, Lee CH, Hwang JJ, Huang CT, Lee CY, Chou ST, Christiani DC, Wu MT. Second-hand smoke and chronic bronchitis in Taiwanese women: a health-care based study. BMC Public Health. 2010;10:44.PubMedPubMedCentralCrossRef Wu CF, Feng NH, Chong IW, Wu KY, Lee CH, Hwang JJ, Huang CT, Lee CY, Chou ST, Christiani DC, Wu MT. Second-hand smoke and chronic bronchitis in Taiwanese women: a health-care based study. BMC Public Health. 2010;10:44.PubMedPubMedCentralCrossRef
24.
go back to reference Raju SV, Tate JH, Peacock SK, Fang P, Oster RA, Dransfield MT, Rowe SM. Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis. Respir Res. 2014;15:18.PubMedPubMedCentralCrossRef Raju SV, Tate JH, Peacock SK, Fang P, Oster RA, Dransfield MT, Rowe SM. Impact of heterozygote CFTR mutations in COPD patients with chronic bronchitis. Respir Res. 2014;15:18.PubMedPubMedCentralCrossRef
25.
go back to reference Pyle LC, Ehrhardt A, Mitchell LH, Fan L, Ren A, Naren AP, Li Y, Clancy JP, Bolger GB, Sorscher EJ, Rowe SM. Regulatory domain phosphorylation to distinguish the mechanistic basis underlying acute CFTR modulators. Am J Phys Lung Cell Mol Phys. 2011;301:L587–97. Pyle LC, Ehrhardt A, Mitchell LH, Fan L, Ren A, Naren AP, Li Y, Clancy JP, Bolger GB, Sorscher EJ, Rowe SM. Regulatory domain phosphorylation to distinguish the mechanistic basis underlying acute CFTR modulators. Am J Phys Lung Cell Mol Phys. 2011;301:L587–97.
26.
go back to reference Clark J, Clore EL, Zheng K, Adame A, Masliah E, Simon DK. Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice. PLoS One. 2010;5:e12333.PubMedPubMedCentralCrossRef Clark J, Clore EL, Zheng K, Adame A, Masliah E, Simon DK. Oral N-acetyl-cysteine attenuates loss of dopaminergic terminals in alpha-synuclein overexpressing mice. PLoS One. 2010;5:e12333.PubMedPubMedCentralCrossRef
27.
go back to reference Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A. 2007;104:18754–9.PubMedPubMedCentralCrossRef Ghosh A, Roy A, Liu X, Kordower JH, Mufson EJ, Hartley DM, Ghosh S, Mosley RL, Gendelman HE, Pahan K. Selective inhibition of NF-kappaB activation prevents dopaminergic neuronal loss in a mouse model of Parkinson's disease. Proc Natl Acad Sci U S A. 2007;104:18754–9.PubMedPubMedCentralCrossRef
28.
go back to reference Sloane PA, Shastry S, Wilhelm A, Courville C, Tang LP, Backer K, Levin E, Raju SV, Li Y, Mazur M, et al. A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. PLoS One. 2012;7:e39809.PubMedPubMedCentralCrossRef Sloane PA, Shastry S, Wilhelm A, Courville C, Tang LP, Backer K, Levin E, Raju SV, Li Y, Mazur M, et al. A pharmacologic approach to acquired cystic fibrosis transmembrane conductance regulator dysfunction in smoking related lung disease. PLoS One. 2012;7:e39809.PubMedPubMedCentralCrossRef
29.
go back to reference Raju SV, Rasmussen L, Sloane PA, Tang LP, Libby EF, Rowe SM. Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice. Respir Res. 2017;18:173.PubMedPubMedCentralCrossRef Raju SV, Rasmussen L, Sloane PA, Tang LP, Libby EF, Rowe SM. Roflumilast reverses CFTR-mediated ion transport dysfunction in cigarette smoke-exposed mice. Respir Res. 2017;18:173.PubMedPubMedCentralCrossRef
30.
go back to reference Liu L, Shastry S, Byan-Parker S, Houser G, KC K, Birket SE, Fernandez CM, Gardecki JA, Grizzle WE, Wilsterman EJ, et al. An autoregulatory mechanism governing mucociliary transport is sensitive to mucus load. Am J Respir Cell Mol Biol. 2014;51:485–93.PubMedPubMedCentralCrossRef Liu L, Shastry S, Byan-Parker S, Houser G, KC K, Birket SE, Fernandez CM, Gardecki JA, Grizzle WE, Wilsterman EJ, et al. An autoregulatory mechanism governing mucociliary transport is sensitive to mucus load. Am J Respir Cell Mol Biol. 2014;51:485–93.PubMedPubMedCentralCrossRef
31.
go back to reference Birket SE, Chu KK, Liu L, Houser GH, Diephuis BJ, Wilsterman EJ, Dierksen G, Mazur M, Shastry S, Li Y, et al. A functional anatomic defect of the cystic fibrosis airway. Am J Respir Crit Care Med. 2014;190:421–32.PubMedPubMedCentralCrossRef Birket SE, Chu KK, Liu L, Houser GH, Diephuis BJ, Wilsterman EJ, Dierksen G, Mazur M, Shastry S, Li Y, et al. A functional anatomic defect of the cystic fibrosis airway. Am J Respir Crit Care Med. 2014;190:421–32.PubMedPubMedCentralCrossRef
32.
go back to reference Raju SV, Lin VY, Liu L, McNicholas CM, Karki S, Sloane PA, Tang L, Jackson PL, Wang W, Wilson L, et al. The cystic fibrosis Transmembrane conductance regulator Potentiator Ivacaftor augments Mucociliary clearance abrogating cystic fibrosis Transmembrane conductance regulator inhibition by cigarette smoke. Am J Respir Cell Mol Biol. 2017;56:99–108.PubMedPubMedCentralCrossRef Raju SV, Lin VY, Liu L, McNicholas CM, Karki S, Sloane PA, Tang L, Jackson PL, Wang W, Wilson L, et al. The cystic fibrosis Transmembrane conductance regulator Potentiator Ivacaftor augments Mucociliary clearance abrogating cystic fibrosis Transmembrane conductance regulator inhibition by cigarette smoke. Am J Respir Cell Mol Biol. 2017;56:99–108.PubMedPubMedCentralCrossRef
33.
go back to reference Lin VY, Fain MD, Jackson PL, Berryhill TF, Wilson LS, Mazur M, Barnes SJ, Blalock JE, Raju SV, Rowe SM. Vaporized E-Cigarette Liquids Induce Ion Transport Dysfunction in Airway Epithelia. Am J Respir Cell Mol Biol. 2018;61(2):16. Lin VY, Fain MD, Jackson PL, Berryhill TF, Wilson LS, Mazur M, Barnes SJ, Blalock JE, Raju SV, Rowe SM. Vaporized E-Cigarette Liquids Induce Ion Transport Dysfunction in Airway Epithelia. Am J Respir Cell Mol Biol. 2018;61(2):16.
34.
go back to reference Hille B. Ionic channels: molecular pores of excitable membranes. Harvey Lect. 1986;82:47–69.PubMed Hille B. Ionic channels: molecular pores of excitable membranes. Harvey Lect. 1986;82:47–69.PubMed
35.
go back to reference Sheppard DN. CFTR channel pharmacology: insight from a flock of clones. Focus on “divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101”. Am J Phys Cell Phys. 2012;302:C24–6.CrossRef Sheppard DN. CFTR channel pharmacology: insight from a flock of clones. Focus on “divergent CFTR orthologs respond differently to the channel inhibitors CFTRinh-172, glibenclamide, and GlyH-101”. Am J Phys Cell Phys. 2012;302:C24–6.CrossRef
37.
go back to reference Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell. 1998;2:397–403.PubMedCrossRef Zabner J, Smith JJ, Karp PH, Widdicombe JH, Welsh MJ. Loss of CFTR chloride channels alters salt absorption by cystic fibrosis airway epithelia in vitro. Mol Cell. 1998;2:397–403.PubMedCrossRef
38.
go back to reference Lin V, Raju VS, Tang L, Li Y, Wilson L, Berryhill T, Mazur M, Jackson PL, Barnes S, Blalock J. Role Of Acrolein In Cigarette Smoke-Induced Mucociliary Clearance Defects. In: C73 NEW MECHANISMS AND THERAPIES IN COPD; 2017. p. A6265. Lin V, Raju VS, Tang L, Li Y, Wilson L, Berryhill T, Mazur M, Jackson PL, Barnes S, Blalock J. Role Of Acrolein In Cigarette Smoke-Induced Mucociliary Clearance Defects. In: C73 NEW MECHANISMS AND THERAPIES IN COPD; 2017. p. A6265.
39.
go back to reference Zhu Q, Sun Z, Jiang Y, Chen F, Wang M. Acrolein scavengers: reactivity, mechanism and impact on health. Mol Nutr Food Res. 2011;55(9):1375.PubMedCrossRef Zhu Q, Sun Z, Jiang Y, Chen F, Wang M. Acrolein scavengers: reactivity, mechanism and impact on health. Mol Nutr Food Res. 2011;55(9):1375.PubMedCrossRef
40.
go back to reference Hamann K, Shi R. Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury. J Neurochem. 2009;111:1348–56.PubMedCrossRef Hamann K, Shi R. Acrolein scavenging: a potential novel mechanism of attenuating oxidative stress following spinal cord injury. J Neurochem. 2009;111:1348–56.PubMedCrossRef
41.
42.
go back to reference Liu L, Chu KK, Houser GH, Diephuis BJ, Li Y, Wilsterman EJ, Shastry S, Dierksen G, Birket SE, Mazur M, et al. Method for quantitative study of airway functional microanatomy using micro-optical coherence tomography. PLoS One. 2013;8:e54473.PubMedPubMedCentralCrossRef Liu L, Chu KK, Houser GH, Diephuis BJ, Li Y, Wilsterman EJ, Shastry S, Dierksen G, Birket SE, Mazur M, et al. Method for quantitative study of airway functional microanatomy using micro-optical coherence tomography. PLoS One. 2013;8:e54473.PubMedPubMedCentralCrossRef
43.
go back to reference Gundavarapu S, Wilder JA, Mishra NC, Rir-Sima-Ah J, Langley RJ, Singh SP, Saeed AI, Jaramillo RJ, Gott KM, Pena-Philippides JC, et al. Role of nicotinic receptors and acetylcholine in mucous cell metaplasia, hyperplasia, and airway mucus formation in vitro and in vivo. J Allergy Clin Immunol. 2012;130:770–80 e711.PubMedPubMedCentralCrossRef Gundavarapu S, Wilder JA, Mishra NC, Rir-Sima-Ah J, Langley RJ, Singh SP, Saeed AI, Jaramillo RJ, Gott KM, Pena-Philippides JC, et al. Role of nicotinic receptors and acetylcholine in mucous cell metaplasia, hyperplasia, and airway mucus formation in vitro and in vivo. J Allergy Clin Immunol. 2012;130:770–80 e711.PubMedPubMedCentralCrossRef
44.
go back to reference Kochanek KDMAJX, Murphy SL, Minino AM, Kung H-C. Deaths: Final Data for 2009. CDC: National Vital Statistics Reports; 2009. p. 60. Kochanek KDMAJX, Murphy SL, Minino AM, Kung H-C. Deaths: Final Data for 2009. CDC: National Vital Statistics Reports; 2009. p. 60.
45.
go back to reference Kesimer M, Ford AA, Ceppe A, Radicioni G, Cao R, Davis CW, Doerschuk CM, Alexis NE, Anderson WH, Henderson AG, et al. Airway Mucin concentration as a marker of chronic bronchitis. N Engl J Med. 2017;377:911–22.PubMedPubMedCentralCrossRef Kesimer M, Ford AA, Ceppe A, Radicioni G, Cao R, Davis CW, Doerschuk CM, Alexis NE, Anderson WH, Henderson AG, et al. Airway Mucin concentration as a marker of chronic bronchitis. N Engl J Med. 2017;377:911–22.PubMedPubMedCentralCrossRef
46.
go back to reference Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL, Worthington EN, Gentzsch M, Kreda SM, Cholon D, et al. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J. 2012;26:533–45.PubMedPubMedCentralCrossRef Clunes LA, Davies CM, Coakley RD, Aleksandrov AA, Henderson AG, Zeman KL, Worthington EN, Gentzsch M, Kreda SM, Cholon D, et al. Cigarette smoke exposure induces CFTR internalization and insolubility, leading to airway surface liquid dehydration. FASEB J. 2012;26:533–45.PubMedPubMedCentralCrossRef
47.
go back to reference Polgreen PM, Brown GD, Hornick DB, Ahmad F, London B, Stoltz DA, Comellas AP. CFTR Heterozygotes Are at Increased Risk of Respiratory Infections: A Population-Based Study. Open Forum Infect Dis. 2018;5:ofy219.PubMedPubMedCentralCrossRef Polgreen PM, Brown GD, Hornick DB, Ahmad F, London B, Stoltz DA, Comellas AP. CFTR Heterozygotes Are at Increased Risk of Respiratory Infections: A Population-Based Study. Open Forum Infect Dis. 2018;5:ofy219.PubMedPubMedCentralCrossRef
48.
go back to reference Ni I, Ji C, Vij N. Second-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-rafts. PLoS One. 2015;10:e0121200.PubMedPubMedCentralCrossRef Ni I, Ji C, Vij N. Second-hand cigarette smoke impairs bacterial phagocytosis in macrophages by modulating CFTR dependent lipid-rafts. PLoS One. 2015;10:e0121200.PubMedPubMedCentralCrossRef
49.
go back to reference Raju SV, Solomon GM, Dransfield MT, Rowe SM. Acquired cystic fibrosis Transmembrane conductance regulator dysfunction in chronic bronchitis and other diseases of mucus clearance. Clin Chest Med. 2016;37:147–58.PubMedCrossRef Raju SV, Solomon GM, Dransfield MT, Rowe SM. Acquired cystic fibrosis Transmembrane conductance regulator dysfunction in chronic bronchitis and other diseases of mucus clearance. Clin Chest Med. 2016;37:147–58.PubMedCrossRef
50.
go back to reference Solomon GM, Raju SV, Dransfield MT, Rowe SM. Therapeutic approaches to acquired cystic fibrosis Transmembrane conductance regulator dysfunction in chronic bronchitis. Ann Am Thorac Soc. 2016;13(Suppl 2):S169–76.PubMedPubMedCentral Solomon GM, Raju SV, Dransfield MT, Rowe SM. Therapeutic approaches to acquired cystic fibrosis Transmembrane conductance regulator dysfunction in chronic bronchitis. Ann Am Thorac Soc. 2016;13(Suppl 2):S169–76.PubMedPubMedCentral
51.
go back to reference Tse HN, Raiteri L, Wong KY, Yee KS, Ng LY, Wai KY, Loo CK, Chan MH. High-dose N-Acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study. Chest. 2013;144:106–18.PubMedCrossRef Tse HN, Raiteri L, Wong KY, Yee KS, Ng LY, Wai KY, Loo CK, Chan MH. High-dose N-Acetylcysteine in stable COPD: the 1-year, double-blind, randomized, placebo-controlled HIACE study. Chest. 2013;144:106–18.PubMedCrossRef
52.
go back to reference Anderson MP, Rich DP, Gregory RJ, Smith AE, Welsh MJ. Generation of cAMP-activated chloride currents by expression of CFTR. Science. 1991;251:679–82.PubMedCrossRef Anderson MP, Rich DP, Gregory RJ, Smith AE, Welsh MJ. Generation of cAMP-activated chloride currents by expression of CFTR. Science. 1991;251:679–82.PubMedCrossRef
53.
go back to reference Cantin AM, Bilodeau G, Ouellet C, Liao J, Hanrahan JW. Oxidant stress suppresses CFTR expression. Am J Phys Cell Phys. 2006;290:C262–70.CrossRef Cantin AM, Bilodeau G, Ouellet C, Liao J, Hanrahan JW. Oxidant stress suppresses CFTR expression. Am J Phys Cell Phys. 2006;290:C262–70.CrossRef
54.
go back to reference Guimbellot JS, Fortenberry JA, Siegal GP, Moore B, Wen H, Venglarik C, Chen YF, Oparil S, Sorscher EJ, Hong JS. Role of oxygen availability in CFTR expression and function. Am J Respir Cell Mol Biol. 2008;39:514–21.PubMedPubMedCentralCrossRef Guimbellot JS, Fortenberry JA, Siegal GP, Moore B, Wen H, Venglarik C, Chen YF, Oparil S, Sorscher EJ, Hong JS. Role of oxygen availability in CFTR expression and function. Am J Respir Cell Mol Biol. 2008;39:514–21.PubMedPubMedCentralCrossRef
55.
go back to reference Chung S, Baumlin N, Dennis JS, Moore R, Salathe SF, Whitney PL, Sabater J, Abraham WM, Kim MD, Salathe M. Electronic cigarette vapor with nicotine causes airway Mucociliary dysfunction preferentially via TRPA1 receptors. Am J Respir Crit Care Med. 2019;200:1134–45.PubMedCrossRef Chung S, Baumlin N, Dennis JS, Moore R, Salathe SF, Whitney PL, Sabater J, Abraham WM, Kim MD, Salathe M. Electronic cigarette vapor with nicotine causes airway Mucociliary dysfunction preferentially via TRPA1 receptors. Am J Respir Crit Care Med. 2019;200:1134–45.PubMedCrossRef
56.
go back to reference Maouche K, Medjber K, Zahm JM, Delavoie F, Terryn C, Coraux C, Pons S, Cloez-Tayarani I, Maskos U, Birembaut P, Tournier JM. Contribution of alpha7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. Proc Natl Acad Sci U S A. 2013;110:4099–104.PubMedPubMedCentralCrossRef Maouche K, Medjber K, Zahm JM, Delavoie F, Terryn C, Coraux C, Pons S, Cloez-Tayarani I, Maskos U, Birembaut P, Tournier JM. Contribution of alpha7 nicotinic receptor to airway epithelium dysfunction under nicotine exposure. Proc Natl Acad Sci U S A. 2013;110:4099–104.PubMedPubMedCentralCrossRef
57.
go back to reference McClure M, Delucas LJ, Wilson L, Ray M, Rowe SM, Wu X, Dai Q, Hong JS, Sorscher EJ, Kappes JC, Barnes S. Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modifications. PEDS. 2011;25(1):7.PubMed McClure M, Delucas LJ, Wilson L, Ray M, Rowe SM, Wu X, Dai Q, Hong JS, Sorscher EJ, Kappes JC, Barnes S. Purification of CFTR for mass spectrometry analysis: identification of palmitoylation and other post-translational modifications. PEDS. 2011;25(1):7.PubMed
58.
go back to reference Alexander NS, Blount A, Zhang S, Skinner D, Hicks SB, Chestnut M, Kebbel FA, Sorscher EJ, Woodworth BA. Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein. Laryngoscope. 2012;122:1193–7.PubMedPubMedCentralCrossRef Alexander NS, Blount A, Zhang S, Skinner D, Hicks SB, Chestnut M, Kebbel FA, Sorscher EJ, Woodworth BA. Cystic fibrosis transmembrane conductance regulator modulation by the tobacco smoke toxin acrolein. Laryngoscope. 2012;122:1193–7.PubMedPubMedCentralCrossRef
59.
go back to reference Moldeus P, Cotgreave IA, Berggren M. Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration. 1986;50(Suppl 1):31–42.PubMedCrossRef Moldeus P, Cotgreave IA, Berggren M. Lung protection by a thiol-containing antioxidant: N-acetylcysteine. Respiration. 1986;50(Suppl 1):31–42.PubMedCrossRef
60.
go back to reference Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593–7.PubMedCrossRef Aruoma OI, Halliwell B, Hoey BM, Butler J. The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic Biol Med. 1989;6:593–7.PubMedCrossRef
61.
go back to reference Cotgreave IA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol. 1997;38:205–27.PubMedCrossRef Cotgreave IA. N-acetylcysteine: pharmacological considerations and experimental and clinical applications. Adv Pharmacol. 1997;38:205–27.PubMedCrossRef
62.
go back to reference Dekhuijzen PN. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J. 2004;23:629–36.PubMedCrossRef Dekhuijzen PN. Antioxidant properties of N-acetylcysteine: their relevance in relation to chronic obstructive pulmonary disease. Eur Respir J. 2004;23:629–36.PubMedCrossRef
63.
go back to reference Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (bronchitis randomized on NAC cost-utility study, BRONCUS): a randomised placebo-controlled trial. Lancet. 2005;365:1552–60.PubMedCrossRef Decramer M, Rutten-van Molken M, Dekhuijzen PN, Troosters T, van Herwaarden C, Pellegrino R, van Schayck CP, Olivieri D, Del Donno M, De Backer W, et al. Effects of N-acetylcysteine on outcomes in chronic obstructive pulmonary disease (bronchitis randomized on NAC cost-utility study, BRONCUS): a randomised placebo-controlled trial. Lancet. 2005;365:1552–60.PubMedCrossRef
64.
go back to reference Tanel A, Averill-Bates DA. Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine. J Pharmacol Exp Ther. 2007;321:73–83.PubMedCrossRef Tanel A, Averill-Bates DA. Inhibition of acrolein-induced apoptosis by the antioxidant N-acetylcysteine. J Pharmacol Exp Ther. 2007;321:73–83.PubMedCrossRef
Metadata
Title
Evaluation of secondhand smoke effects on CFTR function in vivo
Authors
Lawrence W. Rasmussen
Denise Stanford
Krina Patel
S. Vamsee Raju
Publication date
01-12-2020
Publisher
BioMed Central
Published in
Respiratory Research / Issue 1/2020
Electronic ISSN: 1465-993X
DOI
https://doi.org/10.1186/s12931-020-1324-3

Other articles of this Issue 1/2020

Respiratory Research 1/2020 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.